Overexpression of heme oxygenase-1 protects allogeneic thyroid grafts from rejection in naive mice

Masanori Niimi, Motoi Takashina, Hiroshi Takami, Yoshifumi Ikeda, Tomoo Shatari, Kimikazu Hamano, Kensuke Esato, Kenji Matsumoto, Kaori Kameyama, Susumu Kodaira, Kathryn J. Wood

研究成果: Article査読

15 被引用数 (Scopus)


Background. Endocrine allografts are an option for the treatment of endocrine failure. Methods. One lobe of the thyroid was transplanted under the kidney capsule. Results. C57BL/10 (H2b) thyroids were rejected in naive CBA (H2(k)) mice within 14 days after transplantation. When mice were treated with anti-CD4 monoclonal antibodies (mAb), all grafts survived for more than 60 days. The first grafts still survived after second C57BL/10 or Balb/c (H2(d)) thyroid grafts that were transplanted into the same recipients were rejected acutely, which suggests that the primary grafts were modified under anti-CD4 mAb treatment. To confirm this hypothesis, C57BL/10 thyroid grafts from anti-CD4 mAb-treated mice were retransplanted. All grafts survived in naive mice; this correlated with the overexpression of heme oxygenase-1 (HO-1) in the grafts. Next, an inhibitor of HO-1 (zinc protoporphyrin) or control compound (copper protoporphyrin) was injected intraperitoneally after transplantation of C57BL/10 thyroid grafts into the primary CBA recipients that had been treated with anti-CD4 mAb. The grafts in mice that had been treated with zinc protoporphyrin, but not copper protoporphyrin, were rejected when retransplanted to naive recipients. Conclusions. Overexpression of HO-1 correlated with the protection of fully allogeneic thyroid grafts from rejection when retransplanted into naive recipients.

出版ステータスPublished - 2000 12月

ASJC Scopus subject areas

  • 外科


「Overexpression of heme oxygenase-1 protects allogeneic thyroid grafts from rejection in naive mice」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。